Form 4: Dolby Laboratories Executive John Couling Executes Stock Options and Sells Shares

Dolby Laboratories' SVP, Entertainment, John Couling, exercised stock options and sold shares of Class A Common Stock, according to a recent SEC filing.

Summary

• John Couling, SVP of Entertainment at Dolby Laboratories, engaged in multiple transactions involving the company's Class A Common Stock.
• On November 22, 2024, Couling sold 2,000 shares at $81 each and 48,000 shares at $80 each.
• On the same day, he exercised options to acquire 40,000 shares at $33.15 each and 8,000 shares at $64.6 each.
• On November 25, 2024, Couling exercised options to acquire 7,000 shares at $64.6 each and sold 7,000 shares at $80.5 each.
• Following these transactions, Couling directly owns 106,806 shares of Class A Common Stock, which includes 45,029 shares underlying restricted stock units that are subject to vesting.
• The transactions also involved the exercise of employee stock options granted at different prices and vesting schedules.

Sentiment

Score: 5

Explanation: The document is a neutral report of stock transactions, with no inherent positive or negative sentiment. It reflects routine insider activity.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency into the trading activities of insiders.

Comparison to Industry Standards

• Executive stock transactions are a common practice in publicly traded companies like Dolby Laboratories.
• Companies such as Apple, Microsoft, and Google also have executives who regularly exercise stock options and sell shares, as part of their compensation packages.
• The timing and volume of these transactions are often scrutinized by investors for insights into executive sentiment and company performance.

Stakeholder Impact

• The transactions may have a minor impact on the stock price due to the volume of shares sold by the executive.
• Shareholders may view these transactions as a normal part of executive compensation and stock ownership.

Key Dates

Keywords

Dolby Laboratories, stock options, SEC Form 4, insider trading, Class A Common Stock, John Couling, executive compensation, stock sale, stock purchase